InvestorsHub Logo
Followers 21
Posts 1025
Boards Moderated 0
Alias Born 04/07/2008

Re: midastouch017 post# 2508

Saturday, 05/04/2019 8:29:14 AM

Saturday, May 04, 2019 8:29:14 AM

Post# of 3353
Agreed that is a clear factor too. And i completely agree that one cannot say for sure.

However when you see the footage of Mark Bedwell who according to the facebook video Matt Bellina put up, given Mark was "struggling to walk", to running laps in the FDA headquarters after 3 courses of Nurown, either that is the treatment or that is one heck of a placebo.

It is interesting that since the last con-call where management mentioned about the inability to comment about the social media posting for entirely correct reasons, that the video has been removed by Matt. I assume this would be to slow the excitement around the posts which were becoming a burden on the number of communications received by the FDA team and Brainstorm around the trial.

This type of situation is akin to what we are seeing in the Pluristem CLI trial. The images the KOL provided were astounding, and his comments are similar in that, while he said this is a double blind trial, he's never seen such wounds spontaneous heal, so as he said there, either it's the treatment or an astounding placebo.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BCLI News